NATALIA DETRICK: Open Payments
NPI 1700462025 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,817 in 144 payments from 42 companies in 2025. Trend: 2023 $3,020 · 2024 $2,483 · 2025 $3,817
Food & beverage: $3,477Education: $340
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $455 |
| Janssen Biotech, Inc. | 8 | $327 |
| Exelixis Inc. | 7 | $196 |
| SEAGEN INC. | 2 | $195 |
| Novartis Pharmaceuticals Corporation | 10 | $185 |
| Genentech USA, Inc. | 9 | $179 |
| Daiichi Sankyo Inc. | 12 | $175 |
| Incyte Corporation | 3 | $155 |
| E.R. Squibb & Sons, L.L.C. | 3 | $152 |
| Amgen Inc. | 1 | $125 |
Products named: RYBREVANT, TAGRISSO, MONJUVI, Polivy, IMDELLTRA (AMG757), Vanflyta, BREYANZI, Orserdu.
Industry payments across CA — which companies pay providers there.
